Key result
Review details rising pediatric hypertension prevalence following 2017 AAP guidelines and early target organ damage.
Why the study?
Hypertension is a common finding in children and increases the risk for future cardiovascular events, warranting a review of recent advances in pediatric hypertension research.
This review summarizes recent advances in pediatric hypertension, highlighting the impact of new guidelines, environmental and maternal risk factors, and the potential superiority of ACE inhibitors and ARBs for treatment.
Answers are grounded in this paper and cite their sources.
May warrant closer pediatric BP monitoring; leaves open prospective trials on environmental risks and outcomes.
PURPOSE OF REVIEW: Hypertension is a common finding in children, and increases the risk for future cardiovascular events. This review focuses on recent advances in pediatric hypertension research including changes in hypertension guidelines, epidemiology, predictors of hypertension, blood pressure (BP) measurement, effects on target organs, and treatment of hypertension. RECENT FINDINGS: Changes in the 2017 hypertension guidelines by the American Academy of Pediatrics (AAP) have resulted in increased prevalence of elevated BP and hypertension in the United States, and there is no international consensus on these changes. Despite rising pediatric overweight and obesity in China, hypertension prevalence is stable, suggesting multifactorial effects on childhood BP. Maternal diabetes and exposure to particulate matter are associated with higher childhood BP, and body size in infancy and early childhood is a determinant of adult high BP. Children with elevated BP have evidence of target organ damage with altered retinal vasculature and pulse wave velocity parameters compared to normotensive patients. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be the best antihypertensive medications for the pediatric population even for African-American patients. SUMMARY: Research continues to illuminate contributors to pediatric hypertension and demonstrates opportunities for further study on the effects of hypertension and its management in children.
No takes yet. Share an insight, caveat, or question.
Tran et al. (2020) conducted a review in Pediatric hypertension. This review highlights recent advances in pediatric hypertension, noting increased prevalence following 2017 AAP guidelines, environmental risk factors, and early target organ damage in children.
Synapse has enriched 10 related papers. Consider them for comparative context: